At Mayo's recently-concluded Transform conference, speakers highlighted a DNA-based stool test that shown to dramatically increase compliance to colon cancer screening.
For the last two years, the insurance company has been putting patients in 15 categories — such as "control seeker," "follower," "health nut" and "stubborn" — to better target their care and what the company sells them.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.